$18.67
0.070.38%
最終更新: Oct 16, 7:20 AM
$18.99
0.392.1%
Benzinga
Benzinga
Benzinga
金曜日, 10 16
Benzinga
© 2026 Benzinga | All Rights Reserved
Cue Biopharma (CUE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.38 | $-0.11 | $-2.70 | $-2.70 |
| Actual | $-24.14 | $-1.08 | $0.30 | $-2.10 |
| Surprise | -1649.3% | -881.8% | +111.1% | +22.2% |
| Revenue | ||||
| Estimate | $3.0M | $1.0M | $1.0M | $2.4M |
| Actual | $7.9M | $5.7M | $21.9M | $2.1M |
| Surprise | +162.6% | +468.6% | +2094.2% | -9.47% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.60 | $-1.97 |
| Revenue | ||
| Consensus | $1.0M | $1.0M |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-24.14 | $-1.38 | -1649.3 % |
| Q1 | May 14, 2026 | $-1.08 | $-0.11 | -881.8 % |
| Q4 | Mar 16, 2026 | $0.30 | $-2.70 | 111.1 % |
| Q3 | Nov 12, 2025 | $-2.10 | $-2.70 | 22.2 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $7.88M | $3.00M | 162.6 % |
| Q1 | May 14, 2026 | $5.69M | $1.00M | 468.6 % |
| Q4 | Mar 16, 2026 | $21.94M | $1.00M | 2094.2 % |
| Q3 | Nov 12, 2025 | $2.15M | $2.37M | -9.47 % |